Biechele Royce Advisors Buys Schlumberger, Intel Corp, CVS Health Corp, Sells Qualcomm Inc, Starbucks Corp, Sanofi SA

Investment company Biechele Royce Advisors (Current Portfolio) buys Schlumberger, Intel Corp, CVS Health Corp, Exxon Mobil Corp, sells Qualcomm Inc, Starbucks Corp, Sanofi SA, Enterprise Products Partners LP, VanEck Vectors Gold Miners during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Biechele Royce Advisors. As of 2019Q2, Biechele Royce Advisors owns 39 stocks with a total value of $151 million. These are the details of the buys and sells.

For the details of Biechele Royce Advisors's stock buys and sells, go to https://www.gurufocus.com/guru/biechele+royce+advisors/current-portfolio/portfolioportfolio

These are the top 5 holdings of Biechele Royce Advisors
  1. Discovery Inc (DISCA) - 402,938 shares, 8.17% of the total portfolio. Shares reduced by 0.76%
  2. Applied Materials Inc (AMAT) - 222,804 shares, 6.61% of the total portfolio. Shares reduced by 2.09%
  3. Apple Inc (AAPL) - 46,775 shares, 6.11% of the total portfolio. Shares reduced by 1.74%
  4. ON Semiconductor Corp (ON) - 417,321 shares, 5.57% of the total portfolio. Shares added by 1.47%
  5. Intel Corp (INTC) - 172,383 shares, 5.45% of the total portfolio. Shares added by 39.43%
Added: Schlumberger Ltd (SLB)

Biechele Royce Advisors added to a holding in Schlumberger Ltd by 166.84%. The purchase prices were between $34.69 and $47.41, with an estimated average price of $40.35. The stock is now traded at around $40.08. The impact to a portfolio due to this purchase was 2.64%. The holding were 161,003 shares as of .

Added: Intel Corp (INTC)

Biechele Royce Advisors added to a holding in Intel Corp by 39.43%. The purchase prices were between $43.46 and $58.82, with an estimated average price of $49.65. The stock is now traded at around $49.17. The impact to a portfolio due to this purchase was 1.54%. The holding were 172,383 shares as of .

Added: CVS Health Corp (CVS)

Biechele Royce Advisors added to a holding in CVS Health Corp by 27.70%. The purchase prices were between $52.13 and $57.33, with an estimated average price of $53.82. The stock is now traded at around $57.37. The impact to a portfolio due to this purchase was 1.16%. The holding were 149,286 shares as of .

Added: Exxon Mobil Corp (XOM)

Biechele Royce Advisors added to a holding in Exxon Mobil Corp by 20.35%. The purchase prices were between $70.77 and $83.38, with an estimated average price of $77.42. The stock is now traded at around $75.93. The impact to a portfolio due to this purchase was 0.07%. The holding were 8,379 shares as of .

Sold Out: Qualcomm Inc (QCOM)

Biechele Royce Advisors sold out a holding in Qualcomm Inc. The sale prices were between $55.9 and $89.29, with an estimated average price of $73.23.

Sold Out: Starbucks Corp (SBUX)

Biechele Royce Advisors sold out a holding in Starbucks Corp. The sale prices were between $73.96 and $84.69, with an estimated average price of $78.35.

Sold Out: Sanofi SA (SNY)

Biechele Royce Advisors sold out a holding in Sanofi SA. The sale prices were between $40.43 and $44.3, with an estimated average price of $42.5.

Sold Out: Enterprise Products Partners LP (EPD)

Biechele Royce Advisors sold out a holding in Enterprise Products Partners LP. The sale prices were between $27.85 and $29.6, with an estimated average price of $28.81.

Sold Out: VanEck Vectors Gold Miners (GDX)

Biechele Royce Advisors sold out a holding in VanEck Vectors Gold Miners. The sale prices were between $20.17 and $26.17, with an estimated average price of $22.03.

Sold Out: SPDR Gold Trust (GLD)

Biechele Royce Advisors sold out a holding in SPDR Gold Trust. The sale prices were between $119.94 and $134.2, with an estimated average price of $123.59.



Here is the complete portfolio of Biechele Royce Advisors. Also check out:

1. Biechele Royce Advisors's Undervalued Stocks
2. Biechele Royce Advisors's Top Growth Companies, and
3. Biechele Royce Advisors's High Yield stocks
4. Stocks that Biechele Royce Advisors keeps buying